Toggle navigation
Home
Search
Services
Blog
Contact
About
Bisc Phase II
Scheuermann, Richard H.
Search 42 grants from Richard Scheuermann
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
In utero gene editing to cure a metabolic liver disease
Immune defenses against Neisseria gonorrhoeae
UAB Continence Treatment Center
Mechanisms of Microglial Activation and Phagocytosis in*
Phosphorylation/desensitization/internalization of CRFRI
Recently added grants:
Core A: Administration
The role of neuroactive steroids in stress, drug craving and drug use in cocaine use disorders
Core B: Gene Modulation with RNAi and CRISPER
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
Sleep regulates drug relapse and addiction
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI40076-8-0-0
Application #
7543645
Study Section
Project Start
2004-09-29
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$7,409,296
Indirect Cost
Related projects
NIH 2008
N01 AI
Bioinformatics Integration Support Contract for Biodefense
/ Northrop Grumman Information Technology
$1,000,000
NIH 2007
N01 AI
Bisc Phase II
Scheuermann, Richard H. /
$7,409,296
NIH 2007
N01 AI
Bioinformatics Integration Support Contract for Biodefense
/
NIH 2007
N01 AI
Bioinformatics Integration Support Contract for Immune-Mediated Diseases
/
Comments
Be the first to comment on Richard Scheuermann's grant